Materials technology company Xefco has developed a groundbreaking antiviral technology that has the ability to destroy viruses and bacteria within minutes.
The cytokine storm is still a relatively recent discovery, scientifically speaking, and is actively being studied. ProSci enhances this type of research through supplying high-performance antibodies and recombinant proteins for investigating IFNs, ILs, TNF, chemokines, CSF and growth factors.
To support the investigation of SARS-CoV-2 variants, The Native Antigen Company offers a growing range of recombinant mutant spike antigens.
Supernova dyes are a novel range of polymer dyes designed to be brighter than conventional fluorochromes.
The cell culture medium mimics the metabolic profile of human plasma and is designed to provide researchers with a realistic view of cell growth within the human body.
Researchers have found antibodies capable of neutralising tick-borne encephalitis (TBE), a viral infectious disease transmitted by tick bites.
Researchers have created medical gowns for healthcare workers and first responders using paper laminated with a coating of polyethylene — a lightweight thermoplastic.
The US Food and Drug Administration (FDA) has cleared Zymo Research's DNA/RNA Shield collection tube as a Class II medical device, allowing the product to be used as an in vitro diagnostic (IVD) device for COVID-19 testing.
PCR Biosystems has launched a range of IsoFast Bst Polymerase reagents for rapid, robust and sensitive DNA and RNA amplification.
Biosafety follows IICRC S520 Mould Guidelines and Australian Standards to clean and disinfect cool rooms.